Elcora Advanced Materials Corp. (TSX.V:ERA | OTCQB:ECORF) has announced a delay in filing its annual financial statements and management's discussion and analysis for the fiscal year ended March 31, 2024. The delay is due to additional time required to audit transactions of the company's Moroccan subsidiary and enhanced quality controls by auditors. Elcora has been granted a management cease trade order (MCTO) by the Nova Scotia Securities Commission.
The company expects to file the Annual Filings by September 29, 2024. During the MCTO, the public can continue trading Elcora's listed common shares, but the CEO, CFO, and Directors cannot trade. Elcora will issue bi-weekly default status reports until the Annual Filings are completed.
Elcora Advanced Materials Corp. announced potential delays in filing its annual financial statements and management's discussion and analysis for the fiscal year ending March 31, 2024. The company cites additional time needed for auditing transactions from a subsidiary in Morocco and enhanced quality controls by auditors. If filings are not completed by the July 29, 2024 deadline, Elcora will seek a management cease trade order (MCTO) from the Nova Scotia Securities Commission. This MCTO would restrict trading by the company's executives and directors but allow public trading to continue. Updates on the MCTO application will follow in future news releases.
Elcora Advanced Materials Corp. (TSX.V: ERA | Frankfurt: ELM | OTCQB – ECORF) announced a 10-to-1 share consolidation. This move, pending TSX Venture Exchange approval, will reduce the number of outstanding shares from 170,377,013 to approximately 17,037,701. No fractional shares will be issued, with all fractions rounded down. Share prices and convertible securities will adjust proportionately. The company aims to attract more financing opportunities with this consolidation. There will be no changes to the company's name or trading symbol. Further details will be released at a later date.
Elcora Advanced Materials announces the closing of a CDN $102,750 private placement through an 8% interest bearing, unsecured, convertible promissory note maturing on September 27, 2024. The note can be converted into up to 2,055,000 common shares at a conversion price of CDN $0.05 per share. The proceeds will be used for general working capital. All securities are subject to a four-month hold period. The placement is pending final regulatory approvals.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.